The delayed update by the US Food & Drug Administration (FDA) on the manufacturing conditions at a US factory, which halted the release of millions of doses of the coronavirus vaccine of Johnson & Johnson (J&J) worldwide, may come as early as Monday, says a senior health official.

J&J’s vaccines are central to the SA government’s rollout plans as they require only a single shot and are easier to store than the Pfizer/BioNTech double-shot vaccine that is now being provided...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.